These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 8080209)

  • 1. Protection against invasion of the mouse pulmonary epithelium by a monoclonal IgA directed against Shigella flexneri lipopolysaccharide.
    Phalipon A; Michetti P; Kaufmann M; Cavaillon JM; Huerre M; Kraehenbuhl JP; Sansonetti PJ
    Ann N Y Acad Sci; 1994 Aug; 730():356-8. PubMed ID: 8080209
    [No Abstract]   [Full Text] [Related]  

  • 2. Monoclonal immunoglobulin A antibody directed against serotype-specific epitope of Shigella flexneri lipopolysaccharide protects against murine experimental shigellosis.
    Phalipon A; Kaufmann M; Michetti P; Cavaillon JM; Huerre M; Sansonetti P; Kraehenbuhl JP
    J Exp Med; 1995 Sep; 182(3):769-78. PubMed ID: 7544397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune response characterization in a human challenge study with a Shigella flexneri 2a bioconjugate vaccine.
    Clarkson KA; Talaat KR; Alaimo C; Martin P; Bourgeois AL; Dreyer A; Porter CK; Chakraborty S; Brubaker J; Elwood D; Frölich R; DeNearing B; Weerts HP; Feijoo B; Halpern J; Sack D; Riddle MS; Fonck VG; Kaminski RW
    EBioMedicine; 2021 Apr; 66():103308. PubMed ID: 33813141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transient suppression of Shigella flexneri type 3 secretion by a protective O-antigen-specific monoclonal IgA.
    Forbes SJ; Bumpus T; McCarthy EA; Corthésy B; Mantis NJ
    mBio; 2011; 2(3):e00042-11. PubMed ID: 21610121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-reactivity of Shigella flexneri serotype 2a O antigen antibodies following immunization or infection.
    Van De Verg LL; Bendiuk NO; Kotloff K; Marsh MM; Ruckert JL; Puryear JL; Taylor DN; Hartman AB
    Vaccine; 1996 Aug; 14(11):1062-8. PubMed ID: 8879103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parenteral immunization with IpaB/IpaD protects mice against lethal pulmonary infection by Shigella.
    Martinez-Becerra FJ; Scobey M; Harrison K; Choudhari SP; Quick AM; Joshi SB; Middaugh CR; Picking WL
    Vaccine; 2013 May; 31(24):2667-72. PubMed ID: 23602665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoglobulin G (IgG) and IgA subclass pattern of human antibodies to Shigella flexneri and Salmonella serogroup B and D lipopolysaccharide O antigens.
    Persson MA; Ekwall E; Hammarström L; Lindberg AA; Smith CI
    Infect Immun; 1986 Jun; 52(3):834-9. PubMed ID: 3519461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity and protective efficacy offered by a ribosomal-based vaccine from Shigella flexneri 2a.
    Shim DH; Chang SY; Park SM; Jang H; Carbis R; Czerkinsky C; Uematsu S; Akira S; Kweon MN
    Vaccine; 2007 Jun; 25(25):4828-36. PubMed ID: 17507120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Shigella antigen-specific B memory cells are associated with decreased disease severity in subjects challenged with wild-type Shigella flexneri 2a.
    Wahid R; Simon JK; Picking WL; Kotloff KL; Levine MM; Sztein MB
    Clin Immunol; 2013 Jul; 148(1):35-43. PubMed ID: 23649043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Semiquantitative estimation of Shigella antigen-specific antibodies: correlation with disease severity during shigellosis.
    Islam D; Wretlind B; Hammarström L; Christensson B; Lindberg AA
    APMIS; 1996; 104(7-8):563-74. PubMed ID: 8920810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of Shigella vaccine safety and efficacy in an intranasally challenged mouse model.
    Mallett CP; VanDeVerg L; Collins HH; Hale TL
    Vaccine; 1993; 11(2):190-6. PubMed ID: 8438617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody and cytokine responses in a mouse pulmonary model of Shigella flexneri serotype 2a infection.
    van de Verg LL; Mallett CP; Collins HH; Larsen T; Hammack C; Hale TL
    Infect Immun; 1995 May; 63(5):1947-54. PubMed ID: 7729907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specificity of monoclonal antibodies elicited by mucosal infection of BALB/c mice with virulent Shigella flexneri 2a.
    Hartman AB; Van de Verg LL; Mainhart CR; Tall BD; Smith-Gill SJ
    Clin Diagn Lab Immunol; 1996 Sep; 3(5):584-9. PubMed ID: 8877140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predominance of serotype-specific mucosal antibody response in Shigella flexneri-infected humans living in an area of endemicity.
    Rasolofo-Razanamparany V; Cassel-Beraud AM; Roux J; Sansonetti PJ; Phalipon A
    Infect Immun; 2001 Sep; 69(9):5230-4. PubMed ID: 11500390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of bovine milk immunoglobulin concentrate in preventing illness after Shigella flexneri challenge.
    Tacket CO; Binion SB; Bostwick E; Losonsky G; Roy MJ; Edelman R
    Am J Trop Med Hyg; 1992 Sep; 47(3):276-83. PubMed ID: 1524140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum antibodies to lipopolysaccharide and natural immunity to shigellosis in an Israeli military population.
    Cohen D; Green MS; Block C; Rouach T; Ofek I
    J Infect Dis; 1988 May; 157(5):1068-71. PubMed ID: 3283258
    [No Abstract]   [Full Text] [Related]  

  • 17. Parameters underlying successful protection with live attenuated mutants in experimental shigellosis.
    Bernardini ML; Arondel J; Martini I; Aidara A; Sansonetti PJ
    Infect Immun; 2001 Feb; 69(2):1072-83. PubMed ID: 11160004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization and quantitative analysis of serum IgG class and subclass response to Shigella sonnei and Shigella flexneri 2a lipopolysaccharide following natural Shigella infection.
    Robin G; Cohen D; Orr N; Markus I; Slepon R; Ashkenazi S; Keisari Y
    J Infect Dis; 1997 May; 175(5):1128-33. PubMed ID: 9129076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of prior infection with virulent Shigella flexneri 2a on the resistance of monkeys to subsequent infection with Shigella sonnei.
    Formal SB; Oaks EV; Olsen RE; Wingfield-Eggleston M; Snoy PJ; Cogan JP
    J Infect Dis; 1991 Sep; 164(3):533-7. PubMed ID: 1869840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adaptive immune response to Shigella flexneri 2a cydC in immunocompetent mice and mice lacking immunoglobulin A.
    Way SS; Borczuk AC; Goldberg MB
    Infect Immun; 1999 Apr; 67(4):2001-4. PubMed ID: 10085048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.